Non‐syndromic CLN3‐retinal phenotype includes both adult and early onset phenotype, mild nyctalopia, variable loss of visual acuity, and rod‐cone dystrophy with marked diminished rod function and significant but variable cone system dysfunction (Ku et al., 2017). Here, CLN3 is linked to night blindness.